IVIM Health vs. Noom Med: prices, fine print, and the honest verdict

Tirzepatide pricing

IVIM Health: $278 a month all-in at the 10 mg maintenance basis, dose-scaled from a $208 entry, including the mandatory $75/mo membership. Noom Med does not offer tirzepatide.

Semaglutide pricing

On semaglutide, Noom Med wins at $199 versus $224 all-in — $25/mo apart. IVIM Health: Semaglutide runs $224 a month all-in at the standing rate ($149 on intro/plan terms). Noom Med: Semaglutide runs $199 a month all-in — capped at 0.6 mg, a quarter of the trial dose.

Transparency

IVIM Health: Source-verified (verified 2026-08-05); dispensing pharmacy not publicly named. Noom Med: Source-verified (verified 2026-08-08); names its pharmacy — Tailor Made Compounding (named). In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

IVIM Health: membership mandatory for duration; membership mandatory; $75/mo membership recurs until cancelled. Noom Med: 12-week cycles; 12-week billing cycles.

Two ladders, side by side

Titration is where these pricing structures stop being abstractions: IVIM Health scales $208 → ~$278 by 10 mg (titration lands between $832 and $1,112). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.

The semaglutide board

On semaglutide, Noom Med prices at $199 against $224 all-in. Both sit against a verified field floor of $133 and Wegovy's flat $349 brand rate; dual-molecule pricing also sets each program's internal switch cost when a plateau raises the tirzepatide question.

The five normalizations, applied to this pair

1 · All-in, not advertised. IVIM Health's ranked figure is $278 ($203 medication + $75 mandatory membership); Noom Med publishes no figure to normalize. 2 · Maintenance basis. IVIM Health scales from $208 to $278, and the 10 mg figure is the one ranked. 3 · Terms separated. IVIM Health: standing $278, no prepaid tier — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. IVIM Health: source-verified, read 2026-08-05; Noom Med: source-verified, read 2026-08-08. 5 · Pharmacy weighed. IVIM Health names no pharmacy; Noom Med names Tailor Made Compounding (named) — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

IVIM Health: a mandatory $75/mo membership folded into our all-in figure; membership mandatory; commitment: membership mandatory for duration. Noom Med: no membership — the medication figure is the billed figure; 12-week billing cycles; commitment: 12-week cycles. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

IVIM Health carries source-verified pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Noom Med carries source-verified pricing (last read 2026-08-08); pharmacy disclosure is its strong suit — Tailor Made Compounding (named), named 503A/503B partner. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

The switch mechanics are symmetric: new intake, new script, new pharmacy, old plan cancelled in writing. Budget a shipping-gap week, confirm the destination program's price at your current dose (not its starter figure), and if the move is also a molecule change, loop the prescriber in per the switching guide.

Refills, shipping, and the week-to-week reality

Logistics decide more churn than price does, so put them on the record: IVIM Health: shipping included; consultation video visit included in membership; video visit model. Noom Med: shipping included; consultation included; async visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick IVIM Health if its published terms happen to fit your state, format, or timing. Pick Noom Med if the semaglutide line is cheaper here; a named pharmacy is non-negotiable for you; you refuse membership fees on principle. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

If neither one fits

Widen the frame one step and the strongest adjacent options are Mochi Health at $278 (flat, $79 membership included, named pharmacy); Found at $289 (flat, no membership); ShedRx at $289 (dose-scaled, no membership) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The brand benchmark both must beat

Neither program exists in a vacuum: FDA-approved Zepbound sits at $449/month at maintenance (LillyDirect or retail KwikPens, ~$350 on TrumpRx, ~$50 for newly eligible Medicare patients), and Wegovy at a flat $349. The cheaper of these two compounded options saves $2,052/year against the Zepbound benchmark — the number that has to justify accepting a not-FDA-reviewed product, per the full trade analysis. When a compounded quote drifts above ~$350, this benchmark starts winning the argument on its own.

The verdict

With incomplete published pricing on one or both sides, get current figures in writing before enrolling with either. Both records, with dates and sources, live in the pricing database.